Betterlife Pharma Inc.

BETRF·OQB·$0.05Share Price as of 11/2·$7MMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)06/01/26 20-FAnnual report (foreign)06/02/25 20-FAnnual report (foreign)05/30/24 20-F/AAnnual report (foreign, amended)06/06/23 20-FAnnual report (foreign)05/31/23

Disclosures

6-KForeign issuer report09/30/26 6-KForeign issuer report09/15/26 6-KForeign issuer report09/11/26 6-KForeign issuer report08/24/26 6-KForeign issuer report08/05/26

Prospectuses and Registrations

S-1/ARegistration statement (amended)03/16/10 S-1/ARegistration statement (amended)03/04/10 S-1/ARegistration statement (amended)12/03/09 S-1Registration statement (IPO)08/07/09

Proxies

DEF 14ADefinitive proxy02/19/19 DEF 14ADefinitive proxy10/27/17 DEF 14ADefinitive proxy11/28/16 DEF 14ADefinitive proxy11/25/15 DEFR14ADefinitive proxy (revised)08/27/14

Ownership

SC 13GBeneficial ownership09/22/26 Form 3Initial insider ownership03/10/15 Form 5Annual insider statement03/10/15 Form 5Annual insider statement03/10/15 Form 3Initial insider ownership03/03/15

Other

NT 20-FLate filing notification (20-F)06/01/22 NT 20-FLate filing notification (20-F)06/01/20 NT 10-QLate filing notification (10-Q)06/17/19 NT 10-KLate filing notification (10-K)04/30/19 NT 10-QLate filing notification (10-Q)12/18/18